Philippe Weigerstorfer - 02 Jan 2026 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role: Director
Signature: /s/ Amy Trombly as attorney-in-fact
Issuer symbol: SNOA
Transactions as of: 02 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 02 Jan 2026, 17:25:11 UTC
Previous filing: 03 Jan 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Weigerstorfer Philippe	Director	C/O SONOMA PHARMACEUTICALS, INC., 5445 CONESTOGA COURT, SUITE 150, BOULDER	/s/ Amy Trombly as attorney-in-fact	02 Jan 2026	0001751449

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SNOA	Stock option (right to buy)	Award		+10,000	+100%		20,001	02 Jan 2026	Common Stock	10,000	$3.68	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest one third each on 1/2/2027, 1/2/2028 and 1/2/2029, or upon change of control.
F2	The options were awarded and granted to Mr. Weigerstorfer for services performed on the Board of Directors as part of the Company's annual grant of stock options.